RANIBIZUMAB VERSUS VERTEPORFIN PHOTODYNAMIC THERAPY IN ASIAN PATIENTS WITH MYOPIC CHOROIDAL NEOVASCULARIZATION BRILLIANCE, a 12-Month, Randomized, Double-Masked Study

Chen Youxin; Sharma Tarun; Li Xiaorong; Song Yanping; Chang Qing; Lin Renxin; Egger Anna; Foo Arthur; Gekkieva Margarita; Lai Timothy Y. Y.

首页> 外文期刊>Retina >RANIBIZUMAB VERSUS VERTEPORFIN PHOTODYNAMIC THERAPY IN ASIAN PATIENTS WITH MYOPIC CHOROIDAL NEOVASCULARIZATION BRILLIANCE, a 12-Month, Randomized, Double-Masked Study

【24h】

RANIBIZUMAB VERSUS VERTEPORFIN PHOTODYNAMIC THERAPY IN ASIAN PATIENTS WITH MYOPIC CHOROIDAL NEOVASCULARIZATION BRILLIANCE, a 12-Month, Randomized, Double-Masked Study

机译：Ranibizumab与Verteporfin光动力学治疗在亚洲近视脉络膜新生血管中的亮度，一个12个月，随机，双屏蔽的研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: To evaluate the efficacy and safety of 2 dosing regimens of ranibizumab 0.5 mg versus verteporfin photodynamic therapy in Asian patients with visual impairment due to myopic choroidal neovascularization.

机译：目的：评价近视脉络膜新生血管形成的亚洲患者雷哌妥昔单抗0.5mg与维六霉素光动力学治疗的2个给药方案的疗效和安全性。

著录项

来源
《Retina》 |2019年第10期|共10页
作者
Chen Youxin; Sharma Tarun; Li Xiaorong; Song Yanping; Chang Qing; Lin Renxin; Egger Anna; Foo Arthur; Gekkieva Margarita; Lai Timothy Y. Y.;
展开▼
作者单位

Peking Union Med Coll Hosp Dept Ophthalmol Beijing Peoples R China;

Columbia Univ Dept Ophthalmol Edward S Harkness Eye Inst New York NY 10027 USA;

Tianjin Med Univ Hosp Eye Tianjin Peoples R China;

Wuhan Gen Hosp Chinese Peoples Liberat Army Dept Ophthalmol Wuhan Peoples R China;

Fudan Univ Eye &

ENT Hosp Dept Ophthalmol Shanghai Peoples R China;

China Novartis Inst BioMed Res Co Ltd Dept Ophthalmol Shanghai Peoples R China;

Novartis Pharma AG Dept Ophthalmol Basel Switzerland;

Novartis Asia Pacific Pharmaceut Dept Ophthalmol Singapore Singapore;

Novartis Pharma AG Dept Ophthalmol Basel Switzerland;

Chinese Univ Hong Kong Hong Kong Eye Hosp Dept Ophthalmol &

Visual Sci Hong Kong Peoples R China;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词
choroidal neovascularization; myopia anti-VEGF; ranibizumab; photodynamic therapy; clinical trial; Asian patients;

机译：脉络膜新生血管;近视抗VEGF;ranibizumab;光动力疗法;临床试验;亚洲患者;

相似文献

外文文献
中文文献
专利

1. RANIBIZUMAB VERSUS VERTEPORFIN PHOTODYNAMIC THERAPY IN ASIAN PATIENTS WITH MYOPIC CHOROIDAL NEOVASCULARIZATION BRILLIANCE, a 12-Month, Randomized, Double-Masked Study [J] . Chen Youxin, Sharma Tarun, Li Xiaorong, Retina . 2019,第10期

机译：Ranibizumab与Verteporfin光动力学治疗在亚洲近视脉络膜新生血管中的亮度，一个12个月，随机，双屏蔽的研究
2. Efficacy and safety of ranibizumab monotherapy versus ranibizumab in combination with verteporfin photodynamic therapy in patients with polypoidal choroidal vasculopathy: 12-month outcomes in the Japanese cohort of EVEREST II study [J] . Kanji Takahashi, Masahito Ohji, Hiroko Terasaki, Clinical ophthalmology . 2018,第2期

机译：雷尼单抗单药治疗与雷尼单抗联合维替泊芬光动力疗法在多点脉络膜脉络膜血管病患者中的疗效和安全性：日本EVEREST II研究队列的12个月结果
3. Ranibizumab versus verteporfin photodynamic therapy for myopic choroidal neovascularization: Results from RADIANCE [J] . Steinle Nathan, Ghanekar Avanti, Quezada-Ruiz Carlos Investigative ophthalmology & visual science . 2017,第8期

机译：Ranibizumab与近视脉络膜新生血管化的Verteporfin光学动力学治疗：辐射结果
4. Therapeutic response of experimental choroidal neovascularization in mice with photodynamic/photothermal therapy using ICG loaded gold nanorods as a photosensitizer [C] . Rupesh Singh, Julia C. Batoki, Bela Anand-Apte International Photodynamic Association World Congress . 2019

机译：用ICG负载金纳米杆作为光敏剂对小鼠实验脉络膜新生血管形成的疗效
5. Clinical Features of Treated and Untreated Type 1 Idiopathic Macular Telangiectasia Without the Occurrence of Secondary Choroidal Neovascularization Followed for 2 Years in Japanese Patients [D] . 逢坂理恵 2019

机译：在日本患者中治疗和未治疗的1型特发性黄斑部毛细血管扩张症的临床特征为继发性脉络膜新血管形成，随访2年
6. RANIBIZUMAB VERSUS VERTEPORFIN PHOTODYNAMIC THERAPY IN ASIAN PATIENTS WITH MYOPIC CHOROIDAL NEOVASCULARIZATION [O] . Youxin Chen, Tarun Sharma, Xiaorong Li, -1

机译：RANIBIZUMAB VERSUS VERTEPORFIN在亚洲患者中发生肌性脉络膜新生血管的光动力疗法
7. PSS28 Ranibizumab Vs. Verteporfin Photodynamic Therapy for The Treatment Of Myopic Choroidal Neovascularization: Cost Effectiveness Study In Portugal [O] . Montóia B, Guerreiro T, Viriato D 2015

机译：PSS28雷珠单抗Vs. Verteporfin光动力疗法治疗近视脉络膜新生血管：葡萄牙的成本效益研究
8. Macular Photocoagulation Study: Data Collection Forms for Randomized Trials ofSubfoveal Choroidal Neovascularization. (Forms Completed at Clinical Centers) [R] . 1991

机译：黄斑光凝术研究：中心凹脉络膜新生血管随机试验的数据收集形式。（临床中心完成的表格）

RANIBIZUMAB VERSUS VERTEPORFIN PHOTODYNAMIC THERAPY IN ASIAN PATIENTS WITH MYOPIC CHOROIDAL NEOVASCULARIZATION BRILLIANCE, a 12-Month, Randomized, Double-Masked Study

摘要

著录项

相似文献

相关主题

期刊订阅